CJC-1295 (no DAC) 30mg
MOD-GRF (1-29) / CJC-1295 (No DAC) offers a focused tool for researchers studying pathways related to growth-hormone–adjacent signaling and peptide stability. A minimal, precise sequence designed for controlled in-vitro exploration.
Wholesale access
Apply for Wholesale AccessPricing is quoted per order under our at-will wholesale model — based on the products and volumes you need. Apply for partner access to request a quote.
MOD-GRF (1-29) / CJC-1295 (No DAC) reflects a streamlined approach to peptide research. The sequence is structured to allow controlled investigation into growth-hormone–related pathways, receptor engagement, and peptide fragmentation patterns often discussed in preclinical literature.
Research Overview
Studies examine how truncated analogs such as MOD-GRF (1-29) interact with GHRH-related receptors, while CJC-1295 (No DAC) is frequently referenced in the context of in-vitro stability and chain modification considerations. Together, they offer a platform for researchers exploring comparative peptide behavior under defined laboratory conditions.
Key Research Areas Commonly Discussed
- Preclinical exploration of GHRH-pathway interactions
- In-vitro comparison of analog structure and degradation dynamics
- Assessment of receptor-adjacent signaling models
- Evaluation of sequence modifications and their impact on stability in controlled settings
For laboratory research only. Educational reference only.
| Goal | |
|---|---|
| Strength | 30mg |
| Count/Size | 5mL Vial |
